Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …
Neutralizing antibodies for the prevention and treatment of COVID-19
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Neutralizing antibodies (NAbs) are effective in treating COVID-19, but the mechanism of
immune protection is not fully understood. Here, we applied live bioluminescence imaging …
immune protection is not fully understood. Here, we applied live bioluminescence imaging …
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA. 1 and BA. 2
C Planchais, I Fernández, T Bruel… - Journal of Experimental …, 2022 - rupress.org
Disclosures: C. Planchais reported a patent to PCT/EP2022/058777 licensed (SpikImm). I.
Fernández reported a patent to PCT/EP2022/058777 licensed (SpikImm). T. Bruel reported …
Fernández reported a patent to PCT/EP2022/058777 licensed (SpikImm). T. Bruel reported …
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Abstract The coronavirus disease 2019 (COVID-19) pandemic is an exceptional public
health crisis that demands the timely creation of new therapeutics and viral detection. Owing …
health crisis that demands the timely creation of new therapeutics and viral detection. Owing …
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
Z Jia, K Wang, M Xie, J Wu, Y Hu, Y Zhou… - Protein & …, 2024 - academic.oup.com
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has lasted for more than four years …
respiratory syndrome coronavirus-2 (SARS-CoV-2) has lasted for more than four years …
[HTML][HTML] DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD-independent or dependent approach
Objective: Nobody knows when the COVID-19 pandemic will end or when and where the
next coronavirus will outbreak. Therefore, it is still necessary to develop SARS-CoV-2 …
next coronavirus will outbreak. Therefore, it is still necessary to develop SARS-CoV-2 …
Animal models for SARS‐CoV‐2 infection and pathology
Z Bi, W Hong, J Yang, S Lu, X Peng - MedComm, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the etiology of
coronavirus disease 2019 (COVID‐19) pandemic. Current variants including Alpha, Beta …
coronavirus disease 2019 (COVID‐19) pandemic. Current variants including Alpha, Beta …
A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19
Exposure to severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) prompts
humoral immune responses in the human body. As the auxiliary diagnosis of a current …
humoral immune responses in the human body. As the auxiliary diagnosis of a current …
Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens
M Barlev-Gross, S Weiss, A Ben-Shmuel… - Analytical and …, 2021 - Springer
Public health experts emphasize the need for quick, point-of-care SARS-CoV-2 detection as
an effective strategy for controlling virus spread. To this end, many “antigen” detection …
an effective strategy for controlling virus spread. To this end, many “antigen” detection …